AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. CC
  4. [Form 4] The Chemours Company Insider Trading Activity

[Form 4] The Chemours Company Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

On 08/01/2025 AerSale Corp. (ASLE) Chief Financial Officer & Treasurer Martin Garmendia filed a Form 4 detailing new equity compensation.

  • 28,553 restricted stock units (RSUs) granted at no cost; vest 1/3 each on 6/7/2026, 6/7/2027 and 6/7/2028.
  • 57,938 stock options with a $5.91 exercise price; identical vesting schedule; expire 08/01/2035.
After these awards, Garmendia directly holds 187,453 common shares and 99,000 derivative securities. No shares were sold or disposed of. The filing reflects additional insider ownership alignment, but it also introduces incremental potential dilution through new share issuance.

Il 01/08/2025 il Chief Financial Officer e Tesoriere di AerSale Corp. (ASLE), Martin Garmendia, ha presentato un Modulo 4 che dettaglia una nuova compensazione in azioni.

  • 28.553 unit脿 di azioni vincolate (RSU) concesse gratuitamente; maturano per un terzo ciascuna il 07/06/2026, 07/06/2027 e 07/06/2028.
  • 57.938 opzioni su azioni con prezzo di esercizio di 5,91$; stesso calendario di maturazione; scadono il 01/08/2035.
Dopo questi riconoscimenti, Garmendia detiene direttamente 187.453 azioni ordinarie e 99.000 strumenti derivati. Non sono state vendute o cedute azioni. La comunicazione riflette un ulteriore allineamento della propriet脿 interna, ma introduce anche una potenziale diluizione incrementale tramite l'emissione di nuove azioni.

El 01/08/2025, el Director Financiero y Tesorero de AerSale Corp. (ASLE), Martin Garmendia, present贸 un Formulario 4 detallando una nueva compensaci贸n en acciones.

  • 28.553 unidades restringidas de acciones (RSU) otorgadas sin costo; se consolidan en tercios el 07/06/2026, 07/06/2027 y 07/06/2028.
  • 57.938 opciones sobre acciones con un precio de ejercicio de 5,91$; mismo calendario de consolidaci贸n; expiran el 01/08/2035.
Tras estas concesiones, Garmendia posee directamente 187.453 acciones comunes y 99.000 valores derivados. No se vendieron ni dispusieron acciones. La presentaci贸n refleja una mayor alineaci贸n de propiedad interna, pero tambi茅n introduce una posible diluci贸n incremental mediante la emisi贸n de nuevas acciones.

2025雲� 8鞗� 1鞚�, AerSale Corp.(ASLE)鞚� 斓滉碃鞛毂呾瀯鞛� 瓴� 鞛雼措嫻 鞚挫偓鞚� Martin Garmendia臧� 靸堧鞖� 欤检嫕 氤挫儊 雮挫棴鞚� 靸侅劯頌� 旮办灛頃� Form 4毳� 鞝滌稖頄堨姷雼堧嫟.

  • 28,553臧滌潣 鞝滍暅 欤检嫕 雼渼(RSU)臧� 氍挫儊鞙茧 攵�鞐悩鞐堨溂氅�, 臧侁皝 2026雲� 6鞗� 7鞚�, 2027雲� 6鞗� 7鞚�, 2028雲� 6鞗� 7鞚检棎 1/3鞌� 甓岆Μ臧� 頇曥爼霅╇媹雼�.
  • 57,938臧滌潣 欤检嫕 毵れ垬靹犿儩甓�鞚� 頄夓偓 臧�瓴� $5.91搿� 攵�鞐悩鞐堨溂氅�, 霃欖澕頃� 甓岆Μ 頇曥爼 鞚检爼鞚措┌, 2035雲� 8鞗� 1鞚检棎 毵岆霅╇媹雼�.
鞚措煬頃� 靾橃棳 頉� Garmendia電� 歆侅爲 187,453欤检潣 氤错喌欤�鞕赌 99,000臧滌潣 韺岇儩 歃濌秾鞚� 氤挫湢頃橁碃 鞛堨姷雼堧嫟. 欤检嫕鞚� 韺愲Г霅橁卑雮� 觳橂秳霅橃 鞎婌晿鞀惦媹雼�. 鞚措矆 鞝滌稖鞚� 雮措秬鞛� 靻岇湢甓� 鞝曤牞鞚� 臧曧檾頃橃毵�, 靸堧鞖� 欤检嫕 氚滍枆鞚� 韱淀暅 鞛犾灛鞝� 頋劃 臧�電レ劚霃� 頃粯 雮错彫頃橁碃 鞛堨姷雼堧嫟.

Le 01/08/2025, le Directeur Financier et Tr茅sorier d'AerSale Corp. (ASLE), Martin Garmendia, a d茅pos茅 un formulaire 4 d茅taillant une nouvelle compensation en actions.

  • 28 553 unit茅s d'actions restreintes (RSU) attribu茅es gratuitement; acquises par tiers les 07/06/2026, 07/06/2027 et 07/06/2028.
  • 57 938 options d'achat d'actions avec un prix d'exercice de 5,91 $; calendrier d'acquisition identique; expirent le 01/08/2035.
Apr猫s ces attributions, Garmendia d茅tient directement 187 453 actions ordinaires et 99 000 titres d茅riv茅s. Aucune action n'a 茅t茅 vendue ou c茅d茅e. Le d茅p么t refl猫te un alignement accru de la propri茅t茅 interne, mais introduit 茅galement un potentiel de dilution suppl茅mentaire via l'茅mission de nouvelles actions.

Am 01.08.2025 reichte der Chief Financial Officer und Schatzmeister von AerSale Corp. (ASLE), Martin Garmendia, ein Formular 4 ein, das eine neue Aktienverg眉tung detailliert.

  • 28.553 Restricted Stock Units (RSUs) wurden kostenlos gew盲hrt; sie werden jeweils zu einem Drittel am 07.06.2026, 07.06.2027 und 07.06.2028 f盲llig.
  • 57.938 Aktienoptionen mit einem Aus眉bungspreis von 5,91 $; identischer Vesting-Zeitplan; laufen am 01.08.2035 aus.
Nach diesen Zuteilungen h盲lt Garmendia direkt 187.453 Stammaktien und 99.000 derivative Wertpapiere. Es wurden keine Aktien verkauft oder ver盲u脽ert. Die Meldung zeigt eine zus盲tzliche interne Eigent眉merausrichtung, f眉hrt jedoch auch zu einer potenziellen Verw盲sserung durch neue Aktienemissionen.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine equity grant; signals insider commitment but modest dilution risk, overall neutral.

The grants increase the CFO鈥檚 stake without immediate cash outlay, which generally aligns management with shareholders. However, RSUs convert to common stock and options could become in-the-money, adding up to 86,491 possible new shares (RSUs+options) that may dilute existing holders over the next three years. Because the awards are part of the regular 2020 equity plan and no open-market buying occurred, the market impact should be limited. Overall, the filing is informational rather than catalytic.

TL;DR: Standard incentive structure; governance compliant; limited investor impact.

The staggered three-year vesting schedule promotes retention and performance continuity, consistent with best-practice equity plans. Strike price mirrors typical option pricing mechanics and the 10-year term is conventional. No red flags around accelerated vesting or unusual terms. From a governance lens, the filing supports transparent disclosure but does not materially change the company鈥檚 risk profile.

Il 01/08/2025 il Chief Financial Officer e Tesoriere di AerSale Corp. (ASLE), Martin Garmendia, ha presentato un Modulo 4 che dettaglia una nuova compensazione in azioni.

  • 28.553 unit脿 di azioni vincolate (RSU) concesse gratuitamente; maturano per un terzo ciascuna il 07/06/2026, 07/06/2027 e 07/06/2028.
  • 57.938 opzioni su azioni con prezzo di esercizio di 5,91$; stesso calendario di maturazione; scadono il 01/08/2035.
Dopo questi riconoscimenti, Garmendia detiene direttamente 187.453 azioni ordinarie e 99.000 strumenti derivati. Non sono state vendute o cedute azioni. La comunicazione riflette un ulteriore allineamento della propriet脿 interna, ma introduce anche una potenziale diluizione incrementale tramite l'emissione di nuove azioni.

El 01/08/2025, el Director Financiero y Tesorero de AerSale Corp. (ASLE), Martin Garmendia, present贸 un Formulario 4 detallando una nueva compensaci贸n en acciones.

  • 28.553 unidades restringidas de acciones (RSU) otorgadas sin costo; se consolidan en tercios el 07/06/2026, 07/06/2027 y 07/06/2028.
  • 57.938 opciones sobre acciones con un precio de ejercicio de 5,91$; mismo calendario de consolidaci贸n; expiran el 01/08/2035.
Tras estas concesiones, Garmendia posee directamente 187.453 acciones comunes y 99.000 valores derivados. No se vendieron ni dispusieron acciones. La presentaci贸n refleja una mayor alineaci贸n de propiedad interna, pero tambi茅n introduce una posible diluci贸n incremental mediante la emisi贸n de nuevas acciones.

2025雲� 8鞗� 1鞚�, AerSale Corp.(ASLE)鞚� 斓滉碃鞛毂呾瀯鞛� 瓴� 鞛雼措嫻 鞚挫偓鞚� Martin Garmendia臧� 靸堧鞖� 欤检嫕 氤挫儊 雮挫棴鞚� 靸侅劯頌� 旮办灛頃� Form 4毳� 鞝滌稖頄堨姷雼堧嫟.

  • 28,553臧滌潣 鞝滍暅 欤检嫕 雼渼(RSU)臧� 氍挫儊鞙茧 攵�鞐悩鞐堨溂氅�, 臧侁皝 2026雲� 6鞗� 7鞚�, 2027雲� 6鞗� 7鞚�, 2028雲� 6鞗� 7鞚检棎 1/3鞌� 甓岆Μ臧� 頇曥爼霅╇媹雼�.
  • 57,938臧滌潣 欤检嫕 毵れ垬靹犿儩甓�鞚� 頄夓偓 臧�瓴� $5.91搿� 攵�鞐悩鞐堨溂氅�, 霃欖澕頃� 甓岆Μ 頇曥爼 鞚检爼鞚措┌, 2035雲� 8鞗� 1鞚检棎 毵岆霅╇媹雼�.
鞚措煬頃� 靾橃棳 頉� Garmendia電� 歆侅爲 187,453欤检潣 氤错喌欤�鞕赌 99,000臧滌潣 韺岇儩 歃濌秾鞚� 氤挫湢頃橁碃 鞛堨姷雼堧嫟. 欤检嫕鞚� 韺愲Г霅橁卑雮� 觳橂秳霅橃 鞎婌晿鞀惦媹雼�. 鞚措矆 鞝滌稖鞚� 雮措秬鞛� 靻岇湢甓� 鞝曤牞鞚� 臧曧檾頃橃毵�, 靸堧鞖� 欤检嫕 氚滍枆鞚� 韱淀暅 鞛犾灛鞝� 頋劃 臧�電レ劚霃� 頃粯 雮错彫頃橁碃 鞛堨姷雼堧嫟.

Le 01/08/2025, le Directeur Financier et Tr茅sorier d'AerSale Corp. (ASLE), Martin Garmendia, a d茅pos茅 un formulaire 4 d茅taillant une nouvelle compensation en actions.

  • 28 553 unit茅s d'actions restreintes (RSU) attribu茅es gratuitement; acquises par tiers les 07/06/2026, 07/06/2027 et 07/06/2028.
  • 57 938 options d'achat d'actions avec un prix d'exercice de 5,91 $; calendrier d'acquisition identique; expirent le 01/08/2035.
Apr猫s ces attributions, Garmendia d茅tient directement 187 453 actions ordinaires et 99 000 titres d茅riv茅s. Aucune action n'a 茅t茅 vendue ou c茅d茅e. Le d茅p么t refl猫te un alignement accru de la propri茅t茅 interne, mais introduit 茅galement un potentiel de dilution suppl茅mentaire via l'茅mission de nouvelles actions.

Am 01.08.2025 reichte der Chief Financial Officer und Schatzmeister von AerSale Corp. (ASLE), Martin Garmendia, ein Formular 4 ein, das eine neue Aktienverg眉tung detailliert.

  • 28.553 Restricted Stock Units (RSUs) wurden kostenlos gew盲hrt; sie werden jeweils zu einem Drittel am 07.06.2026, 07.06.2027 und 07.06.2028 f盲llig.
  • 57.938 Aktienoptionen mit einem Aus眉bungspreis von 5,91 $; identischer Vesting-Zeitplan; laufen am 01.08.2035 aus.
Nach diesen Zuteilungen h盲lt Garmendia direkt 187.453 Stammaktien und 99.000 derivative Wertpapiere. Es wurden keine Aktien verkauft oder ver盲u脽ert. Die Meldung zeigt eine zus盲tzliche interne Eigent眉merausrichtung, f眉hrt jedoch auch zu einer potenziellen Verw盲sserung durch neue Aktienemissionen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Familiar Calderon Gerardo
(Last) (First) (Middle)
C/O THE CHEMOURS COMPANY
1007 MARKET STREET
(Street)
WILMINGTON DE 19801
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/01/2025 F(1) 923 D $11.5 39,033.9828(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares automatically withheld to satisfy tax obligations on vesting restricted stock units and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.
2. Includes directly owned shares, restricted stock units and dividend equivalent units.
Remarks:
President, Advanced Performance Materials; Power of Attorney attached as Exhibit 24.
/s/ Eric Stein, Attorney-in-Fact 08/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

How many AerSale (ASLE) shares did the CFO acquire?

Martin Garmendia received 28,553 restricted stock units on 08/01/2025.

What is the exercise price of the newly granted ASLE stock options?

The options carry a $5.91 exercise price and expire on 08/01/2035.

When will the RSUs and options granted on 08/01/2025 vest?

Both instruments vest in one-third increments on 6/7/2026, 6/7/2027 and 6/7/2028.

Did the CFO sell any AerSale shares in this filing?

No. The Form 4 shows no dispositions; only grants were reported.

What is the CFO鈥檚 total direct ownership after the transaction?

Garmendia now holds 187,453 common shares and 99,000 derivative securities.
Stock CC logo
Chemours Co

NYSE:CC

CC Rankings

#3001 Ranked by Market Cap
#1142 Ranked by Dividends

CC Latest News

Aug 5, 2025
The Chemours Company Reports Second Quarter 2025 Results
Jul 29, 2025
Chemours Announces Dates for Second Quarter 2025 Earnings Release and Webcast Conference Call
Jun 18, 2025
The Chemours Company Provides Update on Second Quarter 2025 Outlook
Jun 12, 2025
Chemours Appoints Matthew Conti as Chief Human Resources Officer
Jun 10, 2025
Chemours Appoints Industry Vet Nathan Blom as Vice President of Liquid Cooling Growth Portfolio

CC Latest SEC Filings

Aug 6, 2025
[SCHEDULE 13G/A] The Chemours Company SEC Filing
Aug 5, 2025
[Form 4] The Chemours Company Insider Trading Activity
Aug 5, 2025
[Form 4] The Chemours Company Insider Trading Activity
Aug 5, 2025
[Form 4] The Chemours Company Insider Trading Activity
Aug 5, 2025
[10-Q] The Chemours Company Quarterly Earnings Report

CC Stock Data

1.89B
148.90M
0.47%
98.78%
10.69%
Specialty Chemicals
Chemicals & Allied Products
United States
WILMINGTON